These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38511407)

  • 41. Trigger, pathogen, or bystander: the complex nexus linking Epstein- Barr virus and multiple sclerosis.
    Owens GP; Bennett JL
    Mult Scler; 2012 Sep; 18(9):1204-8. PubMed ID: 22685062
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Decreased CD8+ T cell response to Epstein-Barr virus infected B cells in multiple sclerosis is not due to decreased HLA class I expression on B cells or monocytes.
    Pender MP; Csurhes PA; Pfluger CM; Burrows SR
    BMC Neurol; 2011 Aug; 11():95. PubMed ID: 21810280
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Translational Mini-Review Series on B cell subsets in disease. B cells in multiple sclerosis: drivers of disease pathogenesis and Trojan horse for Epstein-Barr virus entry to the central nervous system?
    Meier UC; Giovannoni G; Tzartos JS; Khan G
    Clin Exp Immunol; 2012 Jan; 167(1):1-6. PubMed ID: 22132878
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epstein-Barr Virus and miRNAs: Partners in Crime in the Pathogenesis of Multiple Sclerosis?
    Hassani A; Khan G
    Front Immunol; 2019; 10():695. PubMed ID: 31001286
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Altered prevalence and reactivity of anti-Epstein-Barr virus antibodies in patients with multiple sclerosis.
    Wagner HJ; Hennig H; Jabs WJ; Siekhaus A; Wessel K; Wandinger KP
    Viral Immunol; 2000; 13(4):497-502. PubMed ID: 11192296
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis.
    Pender MP; Csurhes PA; Lenarczyk A; Pfluger CM; Burrows SR
    J Neurol Neurosurg Psychiatry; 2009 May; 80(5):498-505. PubMed ID: 19015225
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis.
    Höllsberg P; Hansen HJ; Haahr S
    Clin Exp Immunol; 2003 Apr; 132(1):137-43. PubMed ID: 12653848
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantitative PCR for Epstein-Barr virus DNA and RNA in multiple sclerosis.
    Lindsey JW; Hatfield LM; Crawford MP; Patel S
    Mult Scler; 2009 Feb; 15(2):153-8. PubMed ID: 18845656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation.
    Serafini B; Severa M; Columba-Cabezas S; Rosicarelli B; Veroni C; Chiappetta G; Magliozzi R; Reynolds R; Coccia EM; Aloisi F
    J Neuropathol Exp Neurol; 2010 Jul; 69(7):677-93. PubMed ID: 20535037
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells.
    Hassani A; Corboy JR; Al-Salam S; Khan G
    PLoS One; 2018; 13(2):e0192109. PubMed ID: 29394264
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis.
    Sargsyan SA; Shearer AJ; Ritchie AM; Burgoon MP; Anderson S; Hemmer B; Stadelmann C; Gattenlöhner S; Owens GP; Gilden D; Bennett JL
    Neurology; 2010 Apr; 74(14):1127-35. PubMed ID: 20220124
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inflammation and Epstein-Barr Virus at the Crossroads of Multiple Sclerosis and Post-Acute Sequelae of COVID-19 Infection.
    Rousseau BA; Bhaduri-McIntosh S
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112929
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis.
    Pender MP
    Neuroscientist; 2011 Aug; 17(4):351-67. PubMed ID: 21075971
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epstein-Barr virus-specific cytokine-induced killer cells for treatment of Epstein-Barr virus-related malignant lymphoma.
    Pfeffermann LM; Pfirrmann V; Huenecke S; Bremm M; Bonig H; Kvasnicka HM; Klingebiel T; Bader P; Rettinger E
    Cytotherapy; 2018 Jun; 20(6):839-850. PubMed ID: 29754771
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epstein-Barr virus, latitude and multiple sclerosis.
    Disanto G; Pakpoor J; Morahan JM; Hall C; Meier UC; Giovannoni G; Ramagopalan SV
    Mult Scler; 2013 Mar; 19(3):362-5. PubMed ID: 22767435
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A role of late Epstein-Barr virus infection in multiple sclerosis.
    Haahr S; Plesner AM; Vestergaard BF; Höllsberg P
    Acta Neurol Scand; 2004 Apr; 109(4):270-5. PubMed ID: 15016009
    [TBL] [Abstract][Full Text] [Related]  

  • 57. T cells specific for different latent and lytic viral proteins efficiently control Epstein-Barr virus-transformed B cells.
    Nowakowska J; Stuehler C; Egli A; Battegay M; Rauser G; Bantug GR; Brander C; Hess C; Khanna N
    Cytotherapy; 2015 Sep; 17(9):1280-91. PubMed ID: 26276009
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epstein-Barr virus and disease activity in multiple sclerosis.
    Buljevac D; van Doornum GJ; Flach HZ; Groen J; Osterhaus AD; Hop W; van Doorn PA; van der Meché FG; Hintzen RQ
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1377-81. PubMed ID: 16170080
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The interaction of Multiple Sclerosis risk loci with Epstein-Barr virus phenotypes implicates the virus in pathogenesis.
    Afrasiabi A; Parnell GP; Swaminathan S; Stewart GJ; Booth DR
    Sci Rep; 2020 Jan; 10(1):193. PubMed ID: 31932685
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of Epstein-Barr virus-specific antibodies in Cypriot multiple sclerosis patients.
    Deeba E; Koptides D; Gaglia E; Constantinou A; Lambrianides A; Pantzaris M; Krashias G; Christodoulou C
    Mol Immunol; 2019 Jan; 105():270-275. PubMed ID: 30562647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.